A Study to Assess the Safety and Pharmacokinetics of Isavuconazole in Healthy Chinese Volunteers

Phase 1 Completed 36 enrolled Astellas Pharma Inc Basilea Pharmaceutica International Ltd · collab

RandomizedCrossoverOpen-label

Summary

The purpose of this study is to evaluate the pharmacokinetic properties of isavuconazole (BAL4815) and the cleavage product (BAL8728) and assess the safety and tolerability after single-dose and steady state (multiple-dose) administration of isavuconazole BAL8557 in healthy Chinese subjects.

Timeline

Start: 2012-08
Primary completion: 2012-11
Completion: 2012-11

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Isavuconazole	Small molecule	—	Oral

Indications

No indication recorded.